Sotac Pharmaceuticals share news, announcements and annual reports
NSE: SOTACPharmaceuticals & Biotechnology
Share price at the NSE close on 28 Oct 2026. Previous close ₹96.50.
28 Oct: open ₹101.25, high ₹101.30, low ₹101.25
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹112 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.90
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.20%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.58
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,400
Sotac Pharmaceuticals has 103 announcements on record, routine notices left out; 4 in the 30 days to 28 Oct 2026, the latest on 8 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Sotac Pharmaceuticals half-yearly results
The board met on 26 May 2026 to consider financial results, dividend and other business matters
Notice filed 18 May 2026
Sotac Pharmaceuticals annual reports, presentations and earnings calls
The company's own documents, latest first.Sotac Pharmaceuticals financials, year by year
Annual reports4
- Annual report, year to Mar 20268 Sep 2026
- Annual report, year to Mar 20255 Sep 2025
- Annual report, year to Mar 202429 Aug 2024
- Annual report, year to Mar 202319 Aug 2023, a zip file
Sotac Pharmaceuticals share news and announcements
Newest first. Page 1 of 3.
Oct 2026
8 Oct · Board meeting
Sep 2026
30 Sep · Meeting
8 Sep · General Updates
8 Sep · Corporate action
Jul 2026
23 Jul · Business
May 2026
26 May · Results
Mar 2026
27 Mar · Board meeting
Feb 2026
Dec 2025
Nov 2025
12 Nov · Results
Oct 2025
Sep 2025
Aug 2025
30 Aug · Corporate action
Jun 2025
May 2025
28 May · Results
22 May · Board meeting
Mar 2025
26 Mar · Board meeting
19 Mar · Updates
Jan 2025
Dec 2024
Oct 2024
29 Oct · Results
29 Oct · Board meeting
24 Oct · Board meeting
Sep 2024
27 Sep · Meeting
Aug 2024
28 Aug · Board meeting
13 Aug · Results
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 27 May 2026Results0.00%−0.2 pts vs Nifty 500market median −0.7% · volume 0.5× usual · The announcement
- 17 Nov 2025Results–market median −0.7% · five sessions −5.0% (−5.6 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 29 May 2025Resultsup 4.61%+4.8 pts vs Nifty 500market median −0.7% · five sessions +4.4% (+2.5 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 4 Mar 2025Board or managers changeddown 5.00%−5.2 pts vs Nifty 500market median 0.0% · five sessions −10.0% (−11.9 pts vs Nifty 500) · volume 12.9× usual · The announcement
- 30 Oct 2024Resultsdown 5.00%−6.1 pts vs Nifty 500market median −0.7% · five sessions −6.2% (−7.5 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 9 Aug 2024Board or managers changedup 1.80%−0.3 pts vs Nifty 500market median 0.0% · five sessions −1.1% (−4.2 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 8 Aug 2023Board or managers changedup 1.19%+0.8 pts vs Nifty 500market median 0.0% · five sessions −6.1% (−5.7 pts vs Nifty 500) · volume 0.1× usual · The announcement
Sotac Pharmaceuticals results filing dates and deadlines
Listed companies must file half-yearly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Dealing with a related party in the period | Year to date to Sep 2025 | Standalone | 2.93 | 6.25 | +113.3% | 12 Nov 2025 | 6 Jan 2026 |